BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19959292)

  • 1. A GTP cyclohydrolase 1 genetic variant delays cancer pain.
    Lötsch J; Klepstad P; Doehring A; Dale O
    Pain; 2010 Jan; 148(1):103-106. PubMed ID: 19959292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain care.
    Doehring A; Freynhagen R; Griessinger N; Zimmermann M; Sittl R; Hentig Nv; Geisslinger G; Lötsch J
    Clin J Pain; 2009; 25(9):781-5. PubMed ID: 19851158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype.
    Tegeder I; Adolph J; Schmidt H; Woolf CJ; Geisslinger G; Lötsch J
    Eur J Pain; 2008 Nov; 12(8):1069-77. PubMed ID: 18374612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk.
    Doehring A; Antoniades C; Channon KM; Tegeder I; Lötsch J
    Mutat Res; 2008; 659(3):195-201. PubMed ID: 18515178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous mutations in GTP-cyclohydrolase-1 reduce BH4 biosynthesis but not pain sensitivity.
    Nasser A; Møller AT; Hellmund V; Thorborg SS; Jespersgaard C; Bjerrum OJ; Dupont E; Nachman G; Lykkesfeldt J; Jensen TS; Møller LB
    Pain; 2018 Jun; 159(6):1012-1024. PubMed ID: 29470312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia.
    Belfer I; Youngblood V; Darbari DS; Wang Z; Diaw L; Freeman L; Desai K; Dizon M; Allen D; Cunnington C; Channon KM; Milton J; Hartley SW; Nolan V; Kato GJ; Steinberg MH; Goldman D; Taylor JG
    Am J Hematol; 2014 Feb; 89(2):187-93. PubMed ID: 24136375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliable screening for a pain-protective haplotype in the GTP cyclohydrolase 1 gene (GCH1) through the use of 3 or fewer single nucleotide polymorphisms.
    Lötsch J; Belfer I; Kirchhof A; Mishra BK; Max MB; Doehring A; Costigan M; Woolf CJ; Geisslinger G; Tegeder I
    Clin Chem; 2007 Jun; 53(6):1010-5. PubMed ID: 17363416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GCH1-polymorphism and pain sensitivity among women with provoked vestibulodynia.
    Heddini U; Bohm-Starke N; Grönbladh A; Nyberg F; Nilsson KW; Johannesson U
    Mol Pain; 2012 Sep; 8():68. PubMed ID: 22971341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain.
    Campbell CM; Edwards RR; Carmona C; Uhart M; Wand G; Carteret A; Kim YK; Frost J; Campbell JN
    Pain; 2009 Jan; 141(1-2):114-8. PubMed ID: 19081190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans.
    Kim H; Dionne RA
    Mol Pain; 2007 Mar; 3():6. PubMed ID: 17343757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
    Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
    Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population.
    Kim SK; Kim SH; Nah SS; Lee JH; Hong SJ; Kim HS; Lee HS; Kim HA; Joung CI; Bae J; Choe JY; Lee SS
    J Rheumatol; 2013 Mar; 40(3):316-22. PubMed ID: 23322459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence.
    Tegeder I; Costigan M; Griffin RS; Abele A; Belfer I; Schmidt H; Ehnert C; Nejim J; Marian C; Scholz J; Wu T; Allchorne A; Diatchenko L; Binshtok AM; Goldman D; Adolph J; Sama S; Atlas SJ; Carlezon WA; Parsegian A; Lötsch J; Fillingim RB; Maixner W; Geisslinger G; Max MB; Woolf CJ
    Nat Med; 2006 Nov; 12(11):1269-77. PubMed ID: 17057711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphic variation of the guanosine triphosphate cyclohydrolase 1 gene predicts outcome in patients undergoing surgical treatment for lumbar degenerative disc disease.
    Kim DH; Dai F; Belfer I; Banco RJ; Martha JF; Tighiouart H; Tromanhauser SG; Jenis LG; Hunter DJ; Schwartz CE
    Spine (Phila Pa 1976); 2010 Oct; 35(21):1909-14. PubMed ID: 20838263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIPA1L2, MIR4697, GCH1 and VPS13C loci and risk of Parkinson's diseases in Iranian population: A case-control study.
    Safaralizadeh T; Jamshidi J; Esmaili Shandiz E; Movafagh A; Fazeli A; Emamalizadeh B; Manafi N; Taghavi S; Tafakhori A; Darvish H
    J Neurol Sci; 2016 Oct; 369():1-4. PubMed ID: 27653855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional polymorphism of the GTP cyclohydrolase 1 gene predicts attention performance.
    Yasuda Y; Hashimoto R; Ohi K; Yamamori H; Fujimoto M; Umeda-Yano S; Fujino H; Fukunaga M; Horiguchi M; Takeda M; Ichinose H
    Neurosci Lett; 2014 Apr; 566():46-9. PubMed ID: 24561090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.
    Zhang L; Rao F; Zhang K; Khandrika S; Das M; Vaingankar SM; Bao X; Rana BK; Smith DW; Wessel J; Salem RM; Rodriguez-Flores JL; Mahata SK; Schork NJ; Ziegler MG; O'Connor DT
    J Clin Invest; 2007 Sep; 117(9):2658-71. PubMed ID: 17717598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide Variants of the BH4 Biosynthesis Pathway Gene GCH1 and the Risk of Orofacial Clefts.
    Hozyasz KK; Mostowska A; Wójcicki P; Lasota A; Zadurska M; Dunin-Wilczyńska I; Jagodziński PP
    Mol Neurobiol; 2016 Jan; 53(1):769-776. PubMed ID: 26215833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer.
    Cronin SJF; Rao S; Tejada MA; Turnes BL; Licht-Mayer S; Omura T; Brenneis C; Jacobs E; Barrett L; Latremoliere A; Andrews N; Channon KM; Latini A; Arvanites AC; Davidow LS; Costigan M; Rubin LL; Penninger JM; Woolf CJ
    Sci Transl Med; 2022 Aug; 14(660):eabj1531. PubMed ID: 36044597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Loci modulate opioid therapy response for cancer pain.
    Galvan A; Skorpen F; Klepstad P; Knudsen AK; Fladvad T; Falvella FS; Pigni A; Brunelli C; Caraceni A; Kaasa S; Dragani TA
    Clin Cancer Res; 2011 Jul; 17(13):4581-7. PubMed ID: 21622719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.